未登录

A

Alexandrosz Czira

icon plc

H指数:7

被引数:224

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Burden of illness among patients with asthma prescribed inhaled corticosteroids/long-acting β2-agonists

NPJ PRIMARY CARE RESPIRATORY MEDICINE

IF4.7

2025-02-260

OAAI

Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study

BMJ OPEN RESPIRATORY RESEARCH

IF3.4

2024-05-213

OAAI

Frequency and economic burden of exacerbations in inhaled corticosteroid/ long-acting beta-agonist-treated patients with asthma: A retrospective US claims study

RESPIRATORY MEDICINE

IF3.1

2024-05-010

PRE

Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US

RESPIRATORY MEDICINE

IF3.1

2024-05-010

PRE

Characteristics, treatment patterns and burden of illness in US patients with asthma newly initiating multiple-inhaler triple therapy

BMJ OPEN RESPIRATORY RESEARCH

IF3.4

2024-03-051

OAAI

Adherence to single and multiple inhaler triple therapies among patients with COPD in the real world in Japan

EUROPEAN RESPIRATORY JOURNAL

IF21

2023-10-270

PRE

ICS-LABA prescribing in asthma (maintenance only and MART), clinical and symptom unmet need in Japan

EUROPEAN RESPIRATORY JOURNAL

IF21

2022-12-010

PRE

Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β2-agonist dual therapy in a primary care setting in England

BMJ OPEN RESPIRATORY RESEARCH

IF3.4

2022-09-281

OAAI

Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis (Jul, 10.1007/s12325-022-02234-x, 2022)

ADVANCES IN THERAPY

IF4

2022-09-020

OAAI

Comparative Efficacy of Umeclidinium/Vilanterol Versus Other Bronchodilators for the Treatment of Chronic Obstructive Pulmonary Disease: A Network Meta-Analysis

芜地铵/维兰特罗与其他支气管扩张剂治疗慢性阻塞性肺疾病的疗效比较: 网络荟萃分析

ADVANCES IN THERAPY

IF4

2022-07-209

OAAI

Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis

ADVANCES IN THERAPY

IF4

2022-07-1721

OAAI

A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma

RESPIRATORY MEDICINE

IF3.1

2022-01-0137

OAAI

Are patients with COPD more adherent to single-inhaler compared with multiple-inhaler triple therapy in a real-world UK primary care treated population?

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-253

PRE

Characteristics and treatment pathways of patients with COPD receiving an inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-251

PRE

Characteristics and treatment pathways of patients with COPD receiving a long-acting muscarinic antagonist/long-acting β2-agonist (LABA/LAMA) in the UK

EUROPEAN RESPIRATORY JOURNAL

IF21

2021-11-250

PRE

ARE PATIENTS WITH COPD MORE ADHERENT TO FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) COMPARED WITH MULTIPLE-INHALER TRIPLE THERAPY IN A REAL-WORLD UK PRIMARY CARE TREATED POPULATION?

IF7.7

2021-11-082

OA

DISCONTINUATION AND RE-INITIATION OF MULTIPLE INHALER TRIPLE THERAPY IN ADULT PATIENTS WITH ASTHMA: A COHORT STUDY

IF8.6

2021-10-011

OA

Treatment patterns in English asthma patients initiating multiple inhaler triple therapy: a cohort study

EUROPEAN RESPIRATORY JOURNAL

IF21

2020-10-282

PRE

The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review

EUROPEAN RESPIRATORY JOURNAL

IF21

2020-10-280

PRE

PRICE-DOSE RELATIONSHIP: THE CASE OF ORAL ONCOLOGY DRUGS IN EU5

VALUE IN HEALTH

IF6

2017-10-010

OAAI